Peritoneal Dialysis Market by Type (Automated Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis), Product (Dialysis Solution, Peritoneal Dialysis Catheters), End Use - Global Forecast 2024-2030

Peritoneal Dialysis Market by Type (Automated Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis), Product (Dialysis Solution, Peritoneal Dialysis Catheters), End Use - Global Forecast 2024-2030

The Peritoneal Dialysis Market size was estimated at USD 5.00 billion in 2023 and expected to reach USD 5.33 billion in 2024, at a CAGR 7.01% to reach USD 8.03 billion by 2030.

Peritoneal dialysis is a medical technique used to draw excess fluid and waste products from the body when the kidneys are not functioning properly. This procedure employs the patient's peritoneum, a membrane lining the abdominal cavity, as a filter. During peritoneal dialysis, a special fluid is introduced into the abdominal cavity through a catheter, where it absorbs waste materials and excess fluids. The fluid is then drained and discarded, typically several times a day. An increase in conditions such as diabetes and hypertension, which are leading causes of CKD, significantly contributes to the demand for peritoneal dialysis. Additionally, there's a growing inclination towards getting dialysis treatment at home due to its convenience and cost-effectiveness, boosting the adoption of peritoneal dialysis. However, the risk of peritonitis, an infection of the peritoneum, which can lead to severe complications, poses significant challenges to peritoneal dialysis. Furthermore, innovations in dialysis solutions and devices aimed at improving patient comfort and treatment efficacy provide opportunities to the manufacturers. Leveraging telehealth for remote monitoring of peritoneal dialysis patients can improve patient outcomes and expand market reach.

Regional Insights

The American region is at the forefront in terms of peritoneal dialysis adoption due to its advanced healthcare system, strong patient support programs, and significant investment in research and patents. Medicare, under the ESRD (End-Stage Renal Disease) benefit, provides coverage for dialysis, encouraging PD due to its cost-effectiveness. Ongoing innovations have focused on improving PD solutions and equipment aimed at enhancing patient safety and convenience. The EU has shown steady growth in PD adoption, with varying rates across countries. Initiatives such as the European Renal Care Providers Association (ERCPA) aim to standardize PD care. Investment in research focuses on improving PD technologies and reducing peritonitis. In wealthier Middle Eastern countries, there is significant investment in healthcare, with growing interest in peritoneal dialysis. In contrast, African countries face challenges related to healthcare infrastructure and affordability. Initiatives in these regions aim to improve access to PD through partnerships and funding from international organizations. With a large ESRD patient population, the APAC is witnessing rapid growth in PD adoption, supported by government reforms in healthcare and investment in dialysis centers. Innovations and localized production of peritoneal dialysis supplies have made the treatment more accessible. Moreover, the APAC benefits from strong research initiatives and technological advancements in peritoneal dialysis.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Peritoneal Dialysis Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Increasing number of end-stage renal failure patients
Rising healthcare expenditure and rising awareness of peritoneal dialysis
Growing prevalence of diabetes and hypertension

Market Restraints

Risks associated with infection of the peritoneum and other complexities

Market Opportunities

Leveraging telehealth for remote monitoring of peritoneal dialysis patients
Innovations in dialysis solutions and devices, aimed at improving patient comfort and treatment efficacy

Market Challenges

Concerns regarding technical complexity and reimbursement policies

Market Segmentation Analysis

Type: Increasing significance for continuous ambulatory peritoneal dialysis as it offers more flexibility and control over the dialysis process
End Use: Patients requiring closer medical supervision often prefer dialysis centers

Market Disruption Analysis

Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Peritoneal Dialysis Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Peritoneal Dialysis Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Mitra Industries Introduces Advanced Triple-Chambered PD Bag for Peritoneal Dialysis

Mitra Industries has launched an innovative triple-chambered peritoneal dialysis (PD) bag designed to significantly enhance patient care for Chronic Kidney Disease (CKD) sufferers. This new product features a near-neutral pH level and low glucose degradation products (GDPs), addressing the limitations of traditional acidic PD solutions that can compromise the peritoneal membrane's function.

Pioneering Advancements in Peritoneal Dialysis: Opterion Health Secures Significant Funding for Clinical Trials

Opterion Health AG has successfully closed a financing round, raising CHF 6.5 million. This fundraising, which witnessed a 60% oversubscription, also saw the issuance of additional option capital amounting to CHF 7.3 million, drawing support from a diverse mix of new and existing investors. The infusion of capital propels the company into the preparatory phases of a Phase I clinical trial for its innovative dialysis solution, which aims to challenge the current market norms.

AWAK Technologies Raises Series B Funding for Innovations in Peritoneal Dialysis

AWAK Technologies has significantly advanced the field of dialysis with its Series B fundraising achievement of over USD 20 million. Co-led by venture capital funds Lion X Ventures and Vickers Venture Partners, with support from Advanced MedTech and Eckuity Capital, this funding is expected to fuel further enhancements of the ultraportable PD device, support ongoing clinical trials with Singapore General Hospital, and spearhead a pivotal U.S. trial anticipated in 2025.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Peritoneal Dialysis Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Peritoneal Dialysis Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Angiplast Pvt. Ltd., Asahi Kasei Corporation, AWAK Technologies, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Cook Group Incorporated, DaVita Inc., Diaverum AB, Fresenius Medical Care AG & Co. KGaA, JDmeditech, JMS Co., Ltd., Medionics International Inc., Medtronic PLC, Mitra Industries, Nipro Corporation, Opterion Health AG, Renax Biomedical Technology Co., Ltd., Terumo Corporation, and Toray Industries, Inc..

Market Segmentation & Coverage

This research report categorizes the Peritoneal Dialysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Automated Peritoneal Dialysis
Continuous Ambulatory Peritoneal Dialysis
Product
Dialysis Solution
Peritoneal Dialysis Catheters
End Use
Dialysis Centers
Home Care Settings
Hospitals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year